← Who reports today · Health Care
CI · Q2 2026
Archived report (Q2 2026). Latest deep dive →
Shareholders' Net Income
$1,660M
up 8.4% y/y
Total Revenues
$71,668M
up 6.7% y/y
The quarter in brief
A huge-flow, thin-margin quarter working as designed — revenues +7% to $71.7B (pharmacy alone $57.2B), shareholders' net income +8% to $1,660M at a 2.3% net margin; the insurance side (Cigna Healthcare, adjusted pre-tax +17%) did the growing while Evernorth pharmacy profit was flat, and the FY adjusted-EPS outlook was raised to ≥$30.45.
All figures in $M.
| Line item | Amount and change |
|---|---|
| Pharmacy Revenues | $57,172 · +6.6% |
| Premiums | $9,859 · +7.7% |
| Fees & Other | $4,365 · +5.5% |
| Net Investment Income | $272 · +15.3% |
| Total Revenues | $71,668 · +6.7% |
| Pharmacy, Medical & Operating Costs ≈ | $69,498 · 97% of revenues — the pass-through river |
| Pretax Income ≈ | $2,170 |
| Income Taxes ≈ | $510 |
| Shareholders' Net Income | $1,660 · +8.4% · 2.3% margin · EPS $6.29 |
Verdict: a huge-flow, thin-margin quarter working as designed — revenues +7% to $71.7B (pharmacy alone $57.2B), shareholders' net income +8% to $1,660M at a 2.3% net margin; the insurance side (Cigna Healthcare, adjusted pre-tax +17%) did the growing while Evernorth pharmacy profit was flat, and the FY adjusted-EPS outlook was raised to ≥$30.45.
Adjusted income from operations $2.05B ($7.78/share, +9%). Shareholders' equity $161.35/share (+7%). Weighted shares 264M (−1.6% y/y).
Source and notation
≈ marks derived lines: the release discloses revenues and segment adjusted pre-tax income; the full expense statement lives in the 10-Q. Source: Cigna press release 8-K EX-99.1 (SEC EDGAR).
Open as an image: CI, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “CI Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/ci/q2-2026. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/ci/q2-2026"><img src="https://whoreportstoday.com/t/ci/q2-2026/sankey.png" alt="CI Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/ci/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/ci/q2-2026/sankey.png
<a href="https://whoreportstoday.com/t/ci/q2-2026">CI Q2 2026 earnings chart (Who Reports Today)</a>
This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Pharmacy is 80% of revenue but not the growth: Evernorth's adjusted pre-tax income was flat ($1,663M, −2%) — the quarter's growth came from Cigna Healthcare (+17% to $1,276M), the insurance segment competitors are struggling with.
- Net margin is 2.3% — a $71.7B revenue river producing $1.7B of income; the pharmacy pass-through model runs on volume, so small ratio shifts move billions.
- Six-month premiums fell from $21.9B to $19.7B while the quarter grew +7.7% — the 2025 Medicare divestiture distorts YTD comparisons; quarterly is the honest read.
- EPS +10% against net income +8% — buybacks trimmed the share count 1.6%.
- Corporate & Other runs at −$389M per quarter — the permanent drag line between the two engines.
What distorts the picture in this report and what to watch beyond the headlines.
CI — CI is a US-based financial services company offering asset management, wealth management, and investment products.
It serves individual and institutional clients through a network of advisors and distribution partners across North America.
More reports: CNC · Q3 2026 · COO · Q3 FY2026 · COR · Q4 FY2026 · CRL · Q3 2026 · CVS · Q3 2026 · DGX · Q3 2026 · DHR · Q3 2026 · DVA · Q3 2026 · DXCM · Q3 2026 · ELV · Q3 2026 · all reports